<code id='5556F262D0'></code><style id='5556F262D0'></style>
    • <acronym id='5556F262D0'></acronym>
      <center id='5556F262D0'><center id='5556F262D0'><tfoot id='5556F262D0'></tfoot></center><abbr id='5556F262D0'><dir id='5556F262D0'><tfoot id='5556F262D0'></tfoot><noframes id='5556F262D0'>

    • <optgroup id='5556F262D0'><strike id='5556F262D0'><sup id='5556F262D0'></sup></strike><code id='5556F262D0'></code></optgroup>
        1. <b id='5556F262D0'><label id='5556F262D0'><select id='5556F262D0'><dt id='5556F262D0'><span id='5556F262D0'></span></dt></select></label></b><u id='5556F262D0'></u>
          <i id='5556F262D0'><strike id='5556F262D0'><tt id='5556F262D0'><pre id='5556F262D0'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:66348

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug
          Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

          DarronCummings/APThebenefitsandrisksofEliLilly’streatmentforAlzheimer’sdiseasewereconfirmedindetaile

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          FDA moves to stop vape shops from selling Elf Bar, Esco Bars

          TheFDAisrampingupitseffortstoforcevapeshopsandotherretailerstostopsellingElfBarandEscoBarproducts.PA